Quinacrine clinical trials
How each study uses Quinacrine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Quinacrine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
Cleveland BioLabs (2) · Medical Research Council (1) · University of California, San Francisco (1) · Victoria Werth (1) · Fox Chase Cancer Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Quinacrine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of Quinacrine in Participants With Cutaneous Lupus ErythematosusRecruitingPhase 2Victoria WerthNCT07694336Written as Quinacrine Hydrochloride
- Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal AdenocarcinomaTerminatedPhase 1/2Fox Chase Cancer CenterNCT01844076Written as Quinacrine and Capecitabine
- Treatment of Advanced Renal Cell Carcinoma With QuinacrineWithdrawnPhase 2Cleveland BioLabsNCT00574483Written as quinacrine
- PRION-1: Quinacrine for Human Prion DiseaseCompletedNot applicableMedical Research CouncilNCT00104663Written as Quinacrine
- CJD (Creutzfeldt-Jakob Disease) Quinacrine StudyCompletedPhase 2University of California, San FranciscoNCT00183092Written as Quinacrine
- Quinacrine Treatment in Patients With Androgen-Independent Prostate CancerCompletedPhase 2Cleveland BioLabsNCT00417274Written as Quinacrine
Codes
What other systems call Quinacrine · ClinicalTrials.gg INT008143
- MeSH (NLM) D011796QuinacrineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) H0C805XYDEQUINACRINEConfirmed FDA, NLM, Wikidata
- RxNorm 9061Confirmed FDA, Wikidata
- Wikidata Q417208quinacrineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87656QuinacrineOne source FDA
- DrugBank DB01103One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011796 | Quinacrine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | H0C805XYDE | QUINACRINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9061 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417208 | quinacrine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87656 | Quinacrine | One source FDA |
| DrugBank | DB01103 | — | One source Wikidata |
Also registered as quinacrine hydrochloride (UNII G6242H2NAA · RxNorm 82092).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.